市场调查报告书
商品编码
1298711
经皮皮肤贴片市场:2023-2028年全球行业趋势、份额、规模、增长、机会和预测Transdermal Skin Patches Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
2022年,全球透皮皮肤贴剂市场规模达到76亿美元。展望未来,IMARC集团预计,到2028年,市场规模将达到100亿美元,在2023-2028年期间呈现4.4%的增长率(CAGR)。
透皮皮肤贴剂指的是一种非侵入性的、易于使用的给药方法,在预定的时间内将恒定和一致的治疗剂量注入血液中。它们由背衬、药物、膜、粘合剂、衬垫、化学增强剂和渗透剂、物理辅助剂和低电流(如离子透析)组成。它们提供稳定的扩散率,取决于皮肤的特点和贴片的设计。如今,它们在世界各地被广泛用作化妆品、外用药和透皮给药系统。
透皮皮肤贴片对治疗心脏和荷尔蒙紊乱、偏头痛、帕金森病、阿尔茨海默氏症、中风、人类免疫缺陷病毒(HIV)、骨质疏松症和不宁腿综合症很有效。因此,患有这些疾病的人口比例大幅增加是推动市场增长的关键因素之一。此外,这些药贴有助于避免传统的口服药途径,降低因静脉或肠外治疗造成的不便,并防止胃肠道毒性、恶心和呕吐。此外,由于服用方便,透皮皮肤贴剂正在获得牵引力,以提高病人在长期治疗慢性疼痛和戒烟治疗中的依从性。除此之外,人们对以可承受的成本获得更好的治疗方法的需求不断升级,加上不同类别药物的临床试验数量大幅增加,对市场产生了积极的影响。此外,压敏胶和渗透增强剂的引入,导致产品扩散的增加和药物保留能力的增强,预计将为市场参与者提供有利可图的机会,并在未来几年内扩大透皮皮肤贴片在全球的应用。
The global transdermal skin patches market size reached US$ 7.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 10.0 Billion by 2028, exhibiting a growth rate (CAGR) of 4.4% during 2023-2028.
Transdermal skin patches refer to a non-invasive and easy to use drug delivery method of administering constant and consistent therapeutic dosages into the bloodstream over a predetermined time. They consist of backings, drugs, membranes, adhesives, liners, chemical enhancers and permeators, physical aids, and low electrical current like iontophoresis. They provide a consistent diffusion rate, depending on the characteristics of the skin and the design of the patch. They are nowadays widely used as cosmetic, topical, and transdermal delivery systems around the world.
Transdermal skin patches are effective for treating cardiac and hormonal disorders, migraine, Parkinson's disease, Alzheimer's, stroke, human immunodeficiency virus (HIV), osteoporosis, and restless leg syndrome. Thus, a significant increase in the percentage of the population suffering from these ailments represents one of the key factors impelling the market growth. Moreover, these patches help avoid the traditional oral route for ingesting medicines, lower the inconvenience caused due to intravenous or parenteral therapies, and prevent gastrointestinal toxicity, nausea, and vomiting. Furthermore, due to the ease of administration, transdermal skin patches are gaining traction to improve the compliance of the patient during prolonged treatments for chronic pains and in smoking cessation therapy. Apart from this, the escalating demand for better therapeutics at affordable costs, coupled with a significant rise in the number of clinical trials of different drugs classes, is positively influencing the market. Furthermore, the introduction of pressure-sensitive adhesives and permeation enhancers, which lead to increased product diffusion and enhanced drug retention ability, is anticipated to provide lucrative opportunities to market players and expand the application of transdermal skin patches across the globe in the coming years.
IMARC Group provides an analysis of the key trends in each sub-segment of the global transdermal skin patches market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, distribution channel and application.
Single-layer Drug-in-Adhesive
Multi-layer Drug-in-Adhesive
Matrix
Others
Hospital Pharmacies
Retail Pharmacies
Online Stores
Pain Relief
Smoking Reduction and Cessation Aid
Overactive Bladder
Hormonal Therapy
Others
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, AdhexPharma, LTS Lohmann Therapie-Systeme AG, Luye Pharma Group?, Medherant Limited, Nitto Denko Corporation, Noven Pharmaceuticals Inc. (Hisamitsu Pharmaceutical Co. Inc.), Prosolus Inc., Samyang Holdings Corporation, Tapemark, Teikoku Pharma USA Inc. (Teikoku Seiyaku Co. Ltd), tesa SE (Beiersdorf AG) and Teva Pharmaceutical Industries Ltd.
Key Questions Answered in This Report
1. What was the size of the global transdermal skin patches market in 2022?
2. What is the expected growth rate of the global transdermal skin patches market during 2023-2028?
3. What are the key factors driving the global transdermal skin patches market?
4. What has been the impact of COVID-19 on the global transdermal skin patches market?
5. What is the breakup of the global transdermal skin patches market based on the type?
6. What is the breakup of the global transdermal skin patches market based on the application?
7. What are the key regions in the global transdermal skin patches market?
8. Who are the key players/companies in the global transdermal skin patches market?